Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-23
    E.g., 2018-06-23

Articles

12160 items
1:44 PM, Jun 19, 2018  |  BC Extra | Financial News

Syncona leads Freeline's £88M series B

Freeline Therapeutics Ltd. (London, U.K.) raised £88.4 million ($116.9 million) in a series B round which included £85 million from lead investor Syncona Ltd. (LSE:SYNC). Fellow founding investor UCL Technology Fund also participated, providing £3.4...
1:08 PM, Jun 19, 2018  |  BC Extra | Financial News

Qiming leads series A for Alpha Biopharma

Alpha Biopharma Inc. (Shanghai, China) raised $37 million in the first tranche of a planned $65 million series A round led by Qiming Venture Partners. The TF Fund and LYZZ Healthcare Venture Fund also participated. Alpha...
4:00 AM, Jun 19, 2018  |  BC Extra | Financial News

Emulate raises $36M series C to improve Organ-Chips offering

Emulate Inc. (Boston, Mass.) raised $36 million in a series C round led by Founders Fund. Fellow new investors ALS Investment Fund, SciFi VC and Glass Wall Syndicate also participated, as did undisclosed existing investors. Emulate...
3:20 PM, Jun 18, 2018  |  BC Extra | Financial News

Qiming leads series B for cancer play WindMIL

WindMIL Therapeutics Inc. (Baltimore, Md.) raised $32.5 million in an untranched series B round led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners Nexus and the Kinneret Group participated alongside existing investors...
3:08 PM, Jun 18, 2018  |  BC Extra | Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

Stealth BioTherapeutics Inc. (Newton, Mass.) raised $100 million Monday through two convertible note rounds led by Nan Fung Technology's Pivotal Beta. Also participating were funds associated with Atlantis Investment Management, BVCF Management, CMBC Capital Holdings,...
1:32 PM, Jun 15, 2018  |  BC Extra | Financial News

Schmidt departing Cowen; Kersten joins Forbion

Eric Schmidt is leaving Cowen as managing director and senior research analyst to join an undisclosed private biotech as CFO. A 20-year veteran of the firm, Schmidt covered over 20 small-, mid- and large-cap biotechs....
7:05 AM, Jun 15, 2018  |  BC Extra | Financial News

Verrica shares jump after $75M IPO

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) added $2.50 (17%) to $17.50 in its first day of trading Friday after the dermatology company raised $75 million through the sale of 5 million shares at $15 in an IPO....
11:06 PM, Jun 13, 2018  |  BC Extra | Financial News

Syncona backs pair of gene therapy start-ups

Syncona Ltd. (LSE:SYNC) launched SwanBio Therapeutics Ltd. (Boston, Mass.) and Orbit Biomedical Ltd. (Philadelphia, Pa.), a pair of gene therapy newcos for CNS and retinal disorders, respectively. The U.K. investment firm provided $23 million of SwanBio's...
4:41 PM, Jun 13, 2018  |  BC Extra | Financial News

British Business Bank launches patient investment fund

British Business Bank launched British Patient Capital on Wednesday, a £2.5 billion ($3.4 billion) investment fund that the bank will invest in U.K. businesses, including bioscience companies, alongside private investors. British Patient Capital fulfills a commitment...
12:26 PM, Jun 13, 2018  |  BC Extra | Financial News

AAV plasmid company StrideBio raises $15.7M series A

StrideBio Inc. (Durham, N.C.) raised $15.7 million in a series A round led by existing investor Hatteras Venture Partners with participation from new investors Takeda Ventures, UCB Ventures and Alexandria Venture Investments. StrideBio COO Richard...

Pages